世界の慢性腰痛治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Chronic Low Back Pain Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1318
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、慢性腰痛治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、薬品）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・慢性腰痛治療の市場動向
・企業の競争状況、市場シェア
・慢性腰痛治療の種類別市場規模（手術、薬品）
・慢性腰痛治療の用途別市場規模（病院、クリニック、外来手術センター、その他）
・慢性腰痛治療の北米市場規模2016-2027（アメリカ、カナダ）
・慢性腰痛治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・慢性腰痛治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・慢性腰痛治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・慢性腰痛治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Johnson & Johnson、Novartis、Takeda Pharmaceutical、Allergan、Teva Pharmaceuticals、Mylan、Stayble Therapeutics、Mesoblast、Axsome Therapeutics）
・結論

Low back pain can be standardized into two categories, acute and chronic. Pain for less than three months can be classified as acute, while continued pain for more than three months is classified as chronic.

Market Analysis and Insights: Global Chronic Low Back Pain Treatment Market
The global Chronic Low Back Pain Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Low Back Pain Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Low Back Pain Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Low Back Pain Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Low Back Pain Treatment market.

Global Chronic Low Back Pain Treatment Scope and Market Size
Chronic Low Back Pain Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Low Back Pain Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgery
Medication

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Johnson & Johnson
Novartis
Takeda Pharmaceutical
Allergan
Teva Pharmaceuticals
Mylan
Stayble Therapeutics
Mesoblast

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Low Back Pain Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Medication
1.3 Market by Application
1.3.1 Global Chronic Low Back Pain Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chronic Low Back Pain Treatment Market Perspective (2016-2027)
2.2 Chronic Low Back Pain Treatment Growth Trends by Regions
2.2.1 Chronic Low Back Pain Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Low Back Pain Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Low Back Pain Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Low Back Pain Treatment Industry Dynamic
2.3.1 Chronic Low Back Pain Treatment Market Trends
2.3.2 Chronic Low Back Pain Treatment Market Drivers
2.3.3 Chronic Low Back Pain Treatment Market Challenges
2.3.4 Chronic Low Back Pain Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chronic Low Back Pain Treatment Players by Revenue
3.1.1 Global Top Chronic Low Back Pain Treatment Players by Revenue (2016-2021)
3.1.2 Global Chronic Low Back Pain Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Low Back Pain Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Low Back Pain Treatment Revenue
3.4 Global Chronic Low Back Pain Treatment Market Concentration Ratio
3.4.1 Global Chronic Low Back Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Low Back Pain Treatment Revenue in 2020
3.5 Chronic Low Back Pain Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Low Back Pain Treatment Product Solution and Service
3.7 Date of Enter into Chronic Low Back Pain Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Low Back Pain Treatment Breakdown Data by Type
4.1 Global Chronic Low Back Pain Treatment Historic Market Size by Type (2016-2021)
4.2 Global Chronic Low Back Pain Treatment Forecasted Market Size by Type (2022-2027)

5 Chronic Low Back Pain Treatment Breakdown Data by Application
5.1 Global Chronic Low Back Pain Treatment Historic Market Size by Application (2016-2021)
5.2 Global Chronic Low Back Pain Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chronic Low Back Pain Treatment Market Size (2016-2027)
6.2 North America Chronic Low Back Pain Treatment Market Size by Type
6.2.1 North America Chronic Low Back Pain Treatment Market Size by Type (2016-2021)
6.2.2 North America Chronic Low Back Pain Treatment Market Size by Type (2022-2027)
6.2.3 North America Chronic Low Back Pain Treatment Market Size by Type (2016-2027)
6.3 North America Chronic Low Back Pain Treatment Market Size by Application
6.3.1 North America Chronic Low Back Pain Treatment Market Size by Application (2016-2021)
6.3.2 North America Chronic Low Back Pain Treatment Market Size by Application (2022-2027)
6.3.3 North America Chronic Low Back Pain Treatment Market Size by Application (2016-2027)
6.4 North America Chronic Low Back Pain Treatment Market Size by Country
6.4.1 North America Chronic Low Back Pain Treatment Market Size by Country (2016-2021)
6.4.2 North America Chronic Low Back Pain Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Chronic Low Back Pain Treatment Market Size (2016-2027)
7.2 Europe Chronic Low Back Pain Treatment Market Size by Type
7.2.1 Europe Chronic Low Back Pain Treatment Market Size by Type (2016-2021)
7.2.2 Europe Chronic Low Back Pain Treatment Market Size by Type (2022-2027)
7.2.3 Europe Chronic Low Back Pain Treatment Market Size by Type (2016-2027)
7.3 Europe Chronic Low Back Pain Treatment Market Size by Application
7.3.1 Europe Chronic Low Back Pain Treatment Market Size by Application (2016-2021)
7.3.2 Europe Chronic Low Back Pain Treatment Market Size by Application (2022-2027)
7.3.3 Europe Chronic Low Back Pain Treatment Market Size by Application (2016-2027)
7.4 Europe Chronic Low Back Pain Treatment Market Size by Country
7.4.1 Europe Chronic Low Back Pain Treatment Market Size by Country (2016-2021)
7.4.2 Europe Chronic Low Back Pain Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chronic Low Back Pain Treatment Market Size (2016-2027)
8.2 Asia-Pacific Chronic Low Back Pain Treatment Market Size by Type
8.2.1 Asia-Pacific Chronic Low Back Pain Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Low Back Pain Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Low Back Pain Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Low Back Pain Treatment Market Size by Application
8.3.1 Asia-Pacific Chronic Low Back Pain Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Low Back Pain Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Low Back Pain Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Low Back Pain Treatment Market Size by Region
8.4.1 Asia-Pacific Chronic Low Back Pain Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Low Back Pain Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chronic Low Back Pain Treatment Market Size (2016-2027)
9.2 Latin America Chronic Low Back Pain Treatment Market Size by Type
9.2.1 Latin America Chronic Low Back Pain Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Low Back Pain Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Low Back Pain Treatment Market Size by Type (2016-2027)
9.3 Latin America Chronic Low Back Pain Treatment Market Size by Application
9.3.1 Latin America Chronic Low Back Pain Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Low Back Pain Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Low Back Pain Treatment Market Size by Application (2016-2027)
9.4 Latin America Chronic Low Back Pain Treatment Market Size by Country
9.4.1 Latin America Chronic Low Back Pain Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Low Back Pain Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chronic Low Back Pain Treatment Market Size (2016-2027)
10.2 Middle East & Africa Chronic Low Back Pain Treatment Market Size by Type
10.2.1 Middle East & Africa Chronic Low Back Pain Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Low Back Pain Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Low Back Pain Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Low Back Pain Treatment Market Size by Application
10.3.1 Middle East & Africa Chronic Low Back Pain Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Low Back Pain Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Low Back Pain Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Low Back Pain Treatment Market Size by Country
10.4.1 Middle East & Africa Chronic Low Back Pain Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Low Back Pain Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Chronic Low Back Pain Treatment Introduction
11.1.4 Pfizer Revenue in Chronic Low Back Pain Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Chronic Low Back Pain Treatment Introduction
11.2.4 Johnson & Johnson Revenue in Chronic Low Back Pain Treatment Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Chronic Low Back Pain Treatment Introduction
11.3.4 Novartis Revenue in Chronic Low Back Pain Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Takeda Pharmaceutical
11.4.1 Takeda Pharmaceutical Company Details
11.4.2 Takeda Pharmaceutical Business Overview
11.4.3 Takeda Pharmaceutical Chronic Low Back Pain Treatment Introduction
11.4.4 Takeda Pharmaceutical Revenue in Chronic Low Back Pain Treatment Business (2016-2021)
11.4.5 Takeda Pharmaceutical Recent Development
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Chronic Low Back Pain Treatment Introduction
11.5.4 Allergan Revenue in Chronic Low Back Pain Treatment Business (2016-2021)
11.5.5 Allergan Recent Development
11.6 Teva Pharmaceuticals
11.6.1 Teva Pharmaceuticals Company Details
11.6.2 Teva Pharmaceuticals Business Overview
11.6.3 Teva Pharmaceuticals Chronic Low Back Pain Treatment Introduction
11.6.4 Teva Pharmaceuticals Revenue in Chronic Low Back Pain Treatment Business (2016-2021)
11.6.5 Teva Pharmaceuticals Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Chronic Low Back Pain Treatment Introduction
11.7.4 Mylan Revenue in Chronic Low Back Pain Treatment Business (2016-2021)
11.7.5 Mylan Recent Development
11.8 Stayble Therapeutics
11.8.1 Stayble Therapeutics Company Details
11.8.2 Stayble Therapeutics Business Overview
11.8.3 Stayble Therapeutics Chronic Low Back Pain Treatment Introduction
11.8.4 Stayble Therapeutics Revenue in Chronic Low Back Pain Treatment Business (2016-2021)
11.8.5 Stayble Therapeutics Recent Development
11.9 Mesoblast
11.9.1 Mesoblast Company Details
11.9.2 Mesoblast Business Overview
11.9.3 Mesoblast Chronic Low Back Pain Treatment Introduction
11.9.4 Mesoblast Revenue in Chronic Low Back Pain Treatment Business (2016-2021)
11.9.5 Mesoblast Recent Development
11.10 Axsome Therapeutics
11.10.1 Axsome Therapeutics Company Details
11.10.2 Axsome Therapeutics Business Overview
11.10.3 Axsome Therapeutics Chronic Low Back Pain Treatment Introduction
11.10.4 Axsome Therapeutics Revenue in Chronic Low Back Pain Treatment Business (2016-2021)
11.10.5 Axsome Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chronic Low Back Pain Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Medication
Table 4. Global Chronic Low Back Pain Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Chronic Low Back Pain Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Chronic Low Back Pain Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Chronic Low Back Pain Treatment Market Share by Regions (2016-2021)
Table 8. Global Chronic Low Back Pain Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Chronic Low Back Pain Treatment Market Share by Regions (2022-2027)
Table 10. Chronic Low Back Pain Treatment Market Trends
Table 11. Chronic Low Back Pain Treatment Market Drivers
Table 12. Chronic Low Back Pain Treatment Market Challenges
Table 13. Chronic Low Back Pain Treatment Market Restraints
Table 14. Global Chronic Low Back Pain Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Chronic Low Back Pain Treatment Market Share by Players (2016-2021)
Table 16. Global Top Chronic Low Back Pain Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Low Back Pain Treatment as of 2020)
Table 17. Ranking of Global Top Chronic Low Back Pain Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Chronic Low Back Pain Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chronic Low Back Pain Treatment Product Solution and Service
Table 21. Date of Enter into Chronic Low Back Pain Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chronic Low Back Pain Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Chronic Low Back Pain Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Chronic Low Back Pain Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Chronic Low Back Pain Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Chronic Low Back Pain Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Chronic Low Back Pain Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Chronic Low Back Pain Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Chronic Low Back Pain Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Chronic Low Back Pain Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Chronic Low Back Pain Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Chronic Low Back Pain Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Chronic Low Back Pain Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Chronic Low Back Pain Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Chronic Low Back Pain Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Chronic Low Back Pain Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Chronic Low Back Pain Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Chronic Low Back Pain Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Chronic Low Back Pain Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Chronic Low Back Pain Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Chronic Low Back Pain Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Chronic Low Back Pain Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Chronic Low Back Pain Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Chronic Low Back Pain Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Chronic Low Back Pain Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chronic Low Back Pain Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Chronic Low Back Pain Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Chronic Low Back Pain Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Chronic Low Back Pain Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Chronic Low Back Pain Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Chronic Low Back Pain Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Chronic Low Back Pain Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Chronic Low Back Pain Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Chronic Low Back Pain Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Chronic Low Back Pain Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Chronic Low Back Pain Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Chronic Low Back Pain Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chronic Low Back Pain Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Chronic Low Back Pain Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Chronic Low Back Pain Treatment Product
Table 64. Pfizer Revenue in Chronic Low Back Pain Treatment Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Chronic Low Back Pain Treatment Product
Table 69. Johnson & Johnson Revenue in Chronic Low Back Pain Treatment Business (2016-2021) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Chronic Low Back Pain Treatment Product
Table 74. Novartis Revenue in Chronic Low Back Pain Treatment Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Takeda Pharmaceutical Company Details
Table 77. Takeda Pharmaceutical Business Overview
Table 78. Takeda Pharmaceutical Chronic Low Back Pain Treatment Product
Table 79. Takeda Pharmaceutical Revenue in Chronic Low Back Pain Treatment Business (2016-2021) & (US$ Million)
Table 80. Takeda Pharmaceutical Recent Development
Table 81. Allergan Company Details
Table 82. Allergan Business Overview
Table 83. Allergan Chronic Low Back Pain Treatment Product
Table 84. Allergan Revenue in Chronic Low Back Pain Treatment Business (2016-2021) & (US$ Million)
Table 85. Allergan Recent Development
Table 86. Teva Pharmaceuticals Company Details
Table 87. Teva Pharmaceuticals Business Overview
Table 88. Teva Pharmaceuticals Chronic Low Back Pain Treatment Product
Table 89. Teva Pharmaceuticals Revenue in Chronic Low Back Pain Treatment Business (2016-2021) & (US$ Million)
Table 90. Teva Pharmaceuticals Recent Development
Table 91. Mylan Company Details
Table 92. Mylan Business Overview
Table 93. Mylan Chronic Low Back Pain Treatment Product
Table 94. Mylan Revenue in Chronic Low Back Pain Treatment Business (2016-2021) & (US$ Million)
Table 95. Mylan Recent Development
Table 96. Stayble Therapeutics Company Details
Table 97. Stayble Therapeutics Business Overview
Table 98. Stayble Therapeutics Revenue in Chronic Low Back Pain Treatment Business (2016-2021) & (US$ Million)
Table 99. Stayble Therapeutics Recent Development
Table 100. Mesoblast Company Details
Table 101. Mesoblast Business Overview
Table 102. Mesoblast Chronic Low Back Pain Treatment Product
Table 103. Mesoblast Revenue in Chronic Low Back Pain Treatment Business (2016-2021) & (US$ Million)
Table 104. Mesoblast Recent Development
Table 105. Axsome Therapeutics Company Details
Table 106. Axsome Therapeutics Business Overview
Table 107. Axsome Therapeutics Chronic Low Back Pain Treatment Product
Table 108. Axsome Therapeutics Revenue in Chronic Low Back Pain Treatment Business (2016-2021) & (US$ Million)
Table 109. Axsome Therapeutics Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Low Back Pain Treatment Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Medication Features
Figure 4. Global Chronic Low Back Pain Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Chronic Low Back Pain Treatment Report Years Considered
Figure 10. Global Chronic Low Back Pain Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Chronic Low Back Pain Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Chronic Low Back Pain Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Chronic Low Back Pain Treatment Market Share by Regions (2022-2027)
Figure 14. Global Chronic Low Back Pain Treatment Market Share by Players in 2020
Figure 15. Global Top Chronic Low Back Pain Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Low Back Pain Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Chronic Low Back Pain Treatment Revenue in 2020
Figure 17. Global Chronic Low Back Pain Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Chronic Low Back Pain Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Chronic Low Back Pain Treatment Market Share by Type (2016-2027)
Figure 21. North America Chronic Low Back Pain Treatment Market Share by Application (2016-2027)
Figure 22. North America Chronic Low Back Pain Treatment Market Share by Country (2016-2027)
Figure 23. United States Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Chronic Low Back Pain Treatment Market Share by Type (2016-2027)
Figure 27. Europe Chronic Low Back Pain Treatment Market Share by Application (2016-2027)
Figure 28. Europe Chronic Low Back Pain Treatment Market Share by Country (2016-2027)
Figure 29. Germany Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Chronic Low Back Pain Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Chronic Low Back Pain Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Chronic Low Back Pain Treatment Market Share by Region (2016-2027)
Figure 39. China Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Chronic Low Back Pain Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Chronic Low Back Pain Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Chronic Low Back Pain Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Chronic Low Back Pain Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Chronic Low Back Pain Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Chronic Low Back Pain Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Chronic Low Back Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Chronic Low Back Pain Treatment Business (2016-2021)
Figure 59. Johnson & Johnson Revenue Growth Rate in Chronic Low Back Pain Treatment Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Chronic Low Back Pain Treatment Business (2016-2021)
Figure 61. Takeda Pharmaceutical Revenue Growth Rate in Chronic Low Back Pain Treatment Business (2016-2021)
Figure 62. Allergan Revenue Growth Rate in Chronic Low Back Pain Treatment Business (2016-2021)
Figure 63. Teva Pharmaceuticals Revenue Growth Rate in Chronic Low Back Pain Treatment Business (2016-2021)
Figure 64. Mylan Revenue Growth Rate in Chronic Low Back Pain Treatment Business (2016-2021)
Figure 65. Stayble Therapeutics Revenue Growth Rate in Chronic Low Back Pain Treatment Business (2016-2021)
Figure 66. Mesoblast Revenue Growth Rate in Chronic Low Back Pain Treatment Business (2016-2021)
Figure 67. Axsome Therapeutics Revenue Growth Rate in Chronic Low Back Pain Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の内臓痛治療市場規模・現状・予測（2021年-2027年）

Global Visceral Pain Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5951 2021年4月 96Pages
QYResearch社発行の本調査資料では、内臓痛治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HS-665、CC-8464、BLU-5937、APD-371、その他）、用途別市場規模（入院、外来）、主要地域別市場規模（北米、アメリカ、ヨ...

世界の慢性肺疾患治療市場規模・現状・予測（2021年-2027年）

Global Chronic Lung Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1319 2021年4月 96Pages
QYResearch社発行の本調査資料では、慢性肺疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、カプセル、錠剤、その他）、用途別市場規模（気管支肺異形成症、喘息、COPD、肺線維症）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の疼痛管理治療薬市場規模・現状・予測（2021年-2027年）

Global Pain Management Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4408 2021年4月 99Pages
QYResearch社発行の本調査資料では、疼痛管理治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗けいれん薬、抗うつ薬、麻酔薬、非ステロイド性抗炎症薬（NSAID）、オピオイド、抗片頭痛薬、その他）、用途別市場規模（神経障害性疼痛、線...

世界の膝痛管理市場規模・現状・予測（2021年-2027年）

Global Knee Pain Management Market Size, Status and Forecast 2021-2027
QYR2104Z3331 2021年4月 91Pages
QYResearch社発行の本調査資料では、膝痛管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（急性膝痛、慢性膝痛）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、Eコマース、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、...

世界の慢性閉塞性肺疾患（COPD）市場規模・現状・予測（2021年-2027年）

Global Chronic Obstructive Pulmonary Disease Market Size, Status and Forecast 2021-2027
QYR2104Z1323 2021年4月 98Pages
QYResearch社発行の本調査資料では、慢性閉塞性肺疾患（COPD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（気管支拡張薬、糖質コルチコイド、その他）、用途別市場規模（予防、診断、治療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の術後疼痛管理市場規模・現状・予測（2021年-2027年）

Global Post-operative Pain Management Market Size, Status and Forecast 2021-2027
QYR2104Z4711 2021年4月 94Pages
QYResearch社発行の本調査資料では、術後疼痛管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬、オピオイド、その他）、用途別市場規模（がん、関節炎、神経障害性、筋骨格痛、片頭痛）、主要地域別市場規模（北米、アメリ...

世界の慢性腎臓病（CKD）市場規模・現状・予測（2021年-2027年）

Global Chronic Kidney Disease (CKD) Market Size, Status and Forecast 2021-2027
QYR2104Z1317 2021年4月 90Pages
QYResearch社発行の本調査資料では、慢性腎臓病（CKD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ACE阻害薬、カルシウム拮抗薬、ベータ遮断薬、その他）、用途別市場規模（病院、専門クリニック）、主要地域別市場規模（北米、アメリカ、...

世界の慢性リンパ性白血病治療市場規模・現状・予測（2021年-2027年）

Global Chronic Lymphocytic Leukemia Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z1320 2021年4月 90Pages
QYResearch社発行の本調査資料では、慢性リンパ性白血病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、経口）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド...

世界の慢性完全閉塞病変（CTO）装置市場規模・現状・予測（2021年-2027年）

Global Chronic Total Occlusion Devices Market Size, Status and Forecast 2021-2027
QYR2104Z1330 2021年4月 99Pages
QYResearch社発行の本調査資料では、慢性完全閉塞病変（CTO）装置のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（マイクロカテーテル、ガイドワイヤー、クロッシング装置、リエントリー装置）、用途別市場規模（病院、クリニック）、主要地域別市...

世界の処方鎮痛剤市場規模・現状・予測（2021年-2027年）

Global Prescription Pain Relievers Market Size, Status and Forecast 2021-2027
QYR2104Z4780 2021年4月 134Pages
QYResearch社発行の本調査資料では、処方鎮痛剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ジェネリックオピオイド、ブランドオピオイド、NSAID、その他）、用途別市場規模（病院、診療所、ドラッグストア）、主要地域別市場規模（北米、ア...

世界の慢性肺疾患治療市場規模・現状・予測（2021年-2027年） Lung disease is a very common medical condition that is present in almost every region of the world. Chronic lung diseases can be dangerous and if not treated properly can cause death. The chronic lung diseases cause uneasiness and complications in the respiratory system thus causing difficulty in r…
世界の内臓痛治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Visceral Pain Treatment Market The global Visceral Pain Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…
世界の膝痛管理市場規模・現状・予測（2021年-2027年） Knee pain is a common pain associated with the bone structure of knee. Knee pain is often associated with age. Knee pain includes: limping due to discomfort, difficulty walking, climbing stairs, locking of knee, redness, swelling and inability to extend knee. The increasing cases of arthritis due to…
世界の疼痛管理治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pain Management Therapeutics Market The global Pain Management Therapeutics market size is projected to reach US$ 67680 million by 2026, from US$ 57740 million in 2019, at a CAGR of 2.3% during 2021-2026. With industry-standard accuracy in analysis and high data …
世界の慢性閉塞性肺疾患（COPD）市場規模・現状・予測（2021年-2027年） Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eve…